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Abstract 
Seroepidemiological surveys were conducted to determine the frequency and distribution of haemorrhagic 
fever virus (HFV) activity in the Central African Republic. Human serum specimens (4295) were collected 
from 5 ecologically distinct zones. Serological evidence of HFV activity was found in all the zones. The filo- 
virus antibody prevalence (24.4%, 1051/4295) was greater than the combined prevalence for Lassa virus, 
Rift Valley fever virus and Crimean-Congo HFV antibody (l.lo/o, 4514295; P<O.Ol). Evidence of filovirus 
activity was found in all zones: 21.3% (91414295) of the population were seropositive for Ebola virus anti- 
body while only 3.2% (13714295) were seroreactive with Marburg viral antigens. Age and sex were import- 
ant host-related factors influencing filovirus activity, particularly in dry grassland and moist forest 
communities. These communities shared many factors, but differences, such as agricultural practices and 
, ethnic backgrounds, may also affect the risk of infection. Filovirus infections appear to occur without appar- 
ent disease. Continued investigations are needed to evaluate the true pathogenicity of the African filoviruses 
and the likelihood that unidentified serologically cross-reacting and non-pathogenic members of the filovirus 
family are active in equatorial Africa. 
Introduction 
The haemorrhagic fever viruses (HFV), which cause 
severe systemic illness with haemorrhagic diathesis, 
plague Africa, causing widely scattered but sporadic 
epidemics of fatal disease. In many instances, highly pa- 
thogenic HFVs such as Lassa virus, Rift Valley fever 
virus, and Crimean-Congo haemorrhagic fever virus cir- 
culate undetected in nature, presumably as enzootic in- 
fections, until conditions change favouring their spread 
to the human population. 
The filoviruses (Marburg and Ebola viruses) are the 
most recently described members of the African HFV 
group. They were identified when severe epidemics oc- 
curred in Europe and Africa during the late 1960s and 
1970s. Marburg virus was first isolated during an 
epidemic in which 30 serious haemorrhagic fever cases, 7 
fatal, occurred in (West) Germany and Yugoslavia (SIE- 
GERT, 1970). The outbreak was associated with the pro- 
cessing of virus-contaminated ussues from African green 
monkeys (Cercopithecus aetkiops) captured in the Lake 
Kyoga region of Uganda (HENDERSON et al., 1971), 
presumably during epidemic and epizootic virus activity 
(SMITH, M. W., 1982). The first recognized Ebola virus 
epidemics in Sudan and Zaire were more devastating; 
hundreds were infected and 60-90% of cases were fatal 
(JOHNSON, 1978; SMITH, D. I. H., 1978). The filo- 
viruses are now considered in the differential diagnosis of 
unexplained fevers occurring in sub-Saharan travellers. 
However, routinely available diagnostic tests and effec- 
uve therapeutic procedures do not exist, and the natural 
history of the filoviruses is unknown. 
In 1984 an attempt was made to define the natural 
threat posed by the filoviruses in equatorial Africa. Ne- 
gative-pressure flexible plastic isolators were installed in 
containment facilities constructed at the Institut Pasteur, 
Bangui, Central African Republic, and the Kenya Medi- 
cal Research Institute, Nairobi, Kenya, to reduce the 
risk among investigators routinely handling potentially 
infectious clinical and environmental specimens (VAN 
DER GROEN, 1982). Subsequently, cross-sectional and 
prospective epidemiological and clinical surveillance 
studies were conducted in which 12 245 serosurvey 
samples and 3473 clinical specimens from fever cases of 
unknown aetiology were assessed for evidence of select 
HFV (Ebola, Marburg, Lassa, Rift Valley fever, and 
Congo-Crimean haemorrhagic fever viruses) activity. 
The earlier findings, from studies which suggested fre- 
The views of the authors do not purport to reflect the positions 
of the Department of the Army or the Department of Defense 
of the USA (para. 4-3, AR 360-5). This article is not copy- 
righted. 
quent filovirus exposure in central Africa, have been 
presented elsewhere (MEUNIER et al., 1987). 
This paper reports the distribution and prevalence of 
endemic HFV activity, as measured by virus reactive 
antibody, and describes epidemiological factors influenc- 
ing filovirus infection in human populations in distinct 
central African environments. The Central African Re- 
public was selected for our study based upon early Insri- 
tut Pasteur reports indicating poteptial virus activity 
there (SALUZZO et al., 1982), its close proximity and eco- 
logical similarity to Sudan and Zaire, and the continued 
interest of local public health officials in investigating the 
viral haemorrhagic fevers. 
Materials and Methods 
Survey areas 
The Central African Republic occupies 620 O00 km2 
between arid Saharan and moist equatorial Africa in the 
geographical centre of the continent. Sixty-one per cent 
of the 2.7 million inhabitants live in rural villages. The 
economy is predominantly agricultural; four-fifths of the 
population are involved in farming. The remaining one- 
fifth are hunter-gatherers who inhabit the tropical forest 
of the south-west. The annual rainfall occurs in 2 sea- 
sons, April to May and August to November, and ranges 
from ap roximately 1800 m3 in Salo south of Nola to 
from moist tropical rain forest in the south to semi-desert 
in the north. Based on climate and vegetation, the terri- 
tory is easily separated into 5 ecologically distinct zones: 
800 mm s in Birao (Figure). The local vegetation varies 
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Survey populations 
Blood samples were obtained from residents of each 
ecological zone. Detailed Sero-surveys were conducted in 
the moist forest areas of Nola and Ikaumba, the pre- 
forest grassland of Bozo and Bangassou, the moist 
wooded grassland of Bouar and Obo, the dry wooded 
grassland near Mbre, and the dry grassland of Birao. 
Single villages were selected in areas such as Bozo and 
Bangassou where ethnic cultures have been amalga- 
mated. Additional villages were surveyed, however, in 
areas of greater population heterogeneity, such as Nola, 
Ikaumba, and Birao, where multiple ethnic groups co- 
exist. 
Survey villages were selected on the basis of accessi- 
bility. All village residents were informed of the mlotive 
and purpose of the research and onIy those who agreed to 
paiticipate were included. If the residents of a chosen vil- 
lage refused, the participation of the nearest neighbour- 
ing village was solicited. 
Sample collection 
Study volunteers were interviewed and a form was 
completed documenting the individual’s name, identifi- 
cation number, estimated age, sex, village of residence, 
length of residence, ethnic group, occupation, father’s 
name, mother’s name and husband’s/wife’s name. 
Venous blood was drawn aseptically from the antecubital 
fossa and allowed to clot overnight at 4°C. Serum was 
separated by centrifugation, dispensed into cryotubes 
and frozen in liquid nitrogen. After transport to the lab- 
oratory, the specimens were thawed, separated into 
aliquots, and refrozen at -20°C until re-thawed, diluted, 
and screened for virus reactive antibody. 
Afn’ca haemorrhagic fever viruses 
The Mayinga strain (Zaïre isolate) and Boniface strain 
(Sudan isolate) of Ebola virus (EBOV), the Musoki strain 
(Kenya isolate) of Marburg virus (MBGV), the Josiah 
strain (Sierra Leone isolate) of Lassa virus (LV)i, the 
10200 strain (Uganda isolate) of Crimean-Congo haemor- 
rhagic fever virus (CCHFV), and the ZH501 strain 
(Egypt isolate) of Rift Valley fever virus (RVFV) were 
used to prepare serological reagents. Except for CCHFV 
and RVFV, working virus stocks were prepared as clari- 
VERT, 1980; GONZALEZ, 1986). 
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fied Vero cell culture supernatant; CCHFV and RVFV 
were prepared as clarified, suckling mouse brain ho- 
mogenates. 
Immunofluorescent antibody test 
An indirect immunofluorescent antibody test (IFAT), 
using inactivated monovalent and polyvalent spot slides 
of acetone-fured virus and. sham-infected or similarly pre- 
pared uninfected material, was used to detect and 
measure HFV reactive antibody activity (JOHNSON et aZ. , 
1981). Monovalent slides were pfepared by mixing unin- 
fected cells at a 10 to 1 ratio with cells infected with a 
single HFV. Polyvalent slides were produced by mixing 
equivalent numbers of sham-infected and HFV-infected 
cells. 
Each serum batch contained coded known HFV anti- 
body-positive samples and was tested ‘double-blind’; 
neither the technician who performed the test nor the 
one worker who evaluated the fluorescent reactions had 
prior knowledge of the test specimens. The survey spe- 
cimens were screened for HFV reactive antibody diluted 
1:16, on polyvalent slides using fluoresce? isothio- 
cyanate-conjugated goat anti-human y-globulm (PEDER- 
SEN et al., 1983). Virus specificity was determined by re- 
screening each IFAT positive serum on a monovalent 
slide. Sera that reacted with infected but not uninfected 
monovalent cell preparations at a 1:16 or greater dilution 
were considered positive. The antibody level was deter- 
mined by titrating the IFAT reactions on monovalent 
slides using 2-fold serial dilutions. Antibody titres were 
recorded as the reciprocal of the last clearly positive dilu- 
tion. Questionable reactions were re-examined by the re- 
viewer and technician and/or an outside observer. The 
tests were repeated when a consensus could not be 
reached. The few sera that produced inconclusive reac- 
tions on retesting were considered non-specsc reactors. 
Statistical analysis 
The significance of differences between HFV antibody 
prevalence rate was determined by the x2 test (SNEDE- 
Results 
A total of 4295 human specimens was collected from 
the 5 ecological zones of the Central African Republic. 
Completed interview forms were available for 94.4% 
(4074/4295) of the population surveyed. As expected 
from the latest available census records (1975), the ma- 
COR & COCHRAN, 1969). 
Table 1. Distribution of Ebola virus and Marburg virus reactions among residents of the Central African Republic 
with anti-filovirus antibody 
Ecological No. with anti- Strain specific EBOV group Family 
zone filovirus antibody EBOVZ EBOVS MBGV (EBOVZ/EBOVS) (EBOV/MBGV) 
Survey population No. positive by IFATa 
Dry grassland 509 35 96 26 323 29 
(7.0) (19.1) (4.2) (64.0) (5.7) 
Dry wooded grassland 37 2 8 3 .  23 
(5.4) (21.6) (8.1) (62.2) 
1 
(2.7) 
Moist wooded grassland 156 5 42 16 56 37 







I 19 2 36 15 
(1.4) (26.4) (2.7) (50.0) (20.8) 
16 40 1 123 7 
(8.6) (21.4) (0.5) (67.9) (0.6) 
59 205 48 561 89 
(6-2) (21.3) (5.0) (58.8) (9.3) .~ . .  
“Indirect fluorescent antibody test: titres 1: 16-1~096. Virus strain-specific reactions, specimens which reacted with only 
one filovirus; EBOV group-specific reactions, specimens which reacted with both Ebola virus strains (EBOZ .and 
EBOS); filovirus family-specific reactions, specimens which reacted with both Ebola virus (EBOV) and Marburg YEUS 
(MBVG). Numbers in parentheses represent precentages of seropositives demonstrating virus strm-specliic or 








Table 2. The distribution of íìlovirus-specific antibody titres in the indirect fluorescent antibody test (Central 
4 3 African Republic) 
IFAT reactions Reciprocal antibody titresb 
TQt antigensa No. positive 32-64 128-256 512-1024 2048-4096 
Filovirus stain specific' 
EBOVZ 59 50 (84.7) 7 (11.9) 2 (3.4) 0 (-1 
EBOVS 206 176 (85.4) 29 (14.1) 1 (0.5) 0 (-) 
MGBV 48 32 (66.7) 13 (27.1) 2 (4.7) l ( 2 . 1 )  
EBOVZ 562 332 (59.0) 193 (34.3) 26 (4.6) 11  (2.0) 
11 (2.0) 
Ebola virus group specific' 
EBOVS 562 309 (54.9) 214 (38-1) 28 (5.0) 
Filovirus family specific' 
EBOVZ 60 49 (81.7) 9 (15.0) 2 (3.3) 0 (-1 
EBOVS 85 66 (77-6) 16 (18.8) 3 (3.5) 0 (-) 
MBGV 89 89 (100) 0 (-) 0 (-1 0 (-> 
"EBOVZ and EBOVS=Ebola virus strains Z and S; MBGV=Marburg virus. 
bNumbers in parentheses are percentages. 
'Specificities are described in Table 1, note a. 
jority of residents tested were S20  years old. Few volun- 
teers reported serious febrile illnesses or haemorrhagic 
disease in their villages. Reports of suspicious disease ac- 
tivity were vigorously investigated, but clinical HFV ac- 
tivity was not documented. 
HFV antibody prevalence 
Serological evidence of HFV activity was found in all 
ecological zones with only a minimal number of non-spe- 
cific IFAT reactions (4-6%, 201/4295). The filovirus 
antibody prevalence (24-4%, 105 1/4295) was greater than 
the combined prevalence for the other HFVs tested (1.1 , 
4514295; P<O-Ol). The IFAT antibody prevalences for 
the non-filovirus African HFVs varied from <0-1 to 
0.7%, and included 33 RVFV, 8 LV and 4 CCHFV anti- 
body seropositives. 
As a group, EBOVs seemed to be active in all ecologi- 
cal zones, with the highest activity in the dry grasslands 
(21.2%, 483/2284), moist wooded grasslands (26.8%, 
140/522), and moist forest (23.0%, 186/807). Evidence of 
lower activity was found in the dry wooded (13%, 
33/256) and pre-forest (16-4%, 71/426) grasslands. 
MBGV activity seemed to be limited, however, to the 
moist wooded and pre-forest grasslands ( 7 ~ 4 % ~  70/948; 
P<O.OI). Lower activity was observed in the dry grass- 
lands (2.4%, 55/2284), dry wooded grasslands (1.5%, 
4/256), andmoist forest (1.0%, 81807). 
Filovirus antibody prevalence 
The majority of filovirus seroreactive specimens (86O/o, 
825/962) reacted with EBOV and not with MBGV 
antigens (Table 1). Sixty-eight percent (5611825) of the 
EBOV reactive samples reacted with both EBOVZ and 
EBOVS viral antigens and were considered seropositive 
for EBOV group specific antibody. The percentages of 
EBOV group reactives in the dry grasslands and moist 
forest were higher than in any other zone (P<O.OI). 
Broad filovirus family (EBOV and MBGV) reactions 
were observed in 9.3% of the seropositive samples. 
Filovirus strain (EBOVZ, EBOVS, or MBGV) specific 
responses were also observed (Table 1). Previously, 
EBOVS specific serological reactions in field surveys 
have been rare, strain specific reactions having been 
against EBOVZ antigens exclusively (BLACKBURN et al., 
1982; IVANOFF et al., 1982). The EBOV strain-specific 
responses were not restricted to a single ecological zone. 
The frequency of MBGV specific IFAT reactions in 
different ecological zones ranged from 0.5% in the moist 
forest to 10.3% in the moist wooded grassland zone. The 
low frequency of MBGV reactive antibody in the moister 
forest and pre-forest areas suggested that MBGV activity 
may be rare in the tropical forests of central Africa. Simi- 
larly, in eastern and southern Africa fatal human MBGV 
infections have occurred predominantly in dry wooded 
grassland habitats (SMITH, D. I .  H. et al., 1982; SWANE- 
POEL, 1987; JOHNSON, E. D. et al., 1993). 
The distribution of filovirus IFAT titres (Table 2) was 
similar to that in areas of Central and West Africa where 
HFV activity was confirmed by virus isolation from clini- 
cal cases (MCCORMICK et al., 1987). Two-thirds 
(1099/167 1) of the positive serological reactions had rela- 
tively low titres (664), but the remainder often reached 
2048. The distribution of antibody titre differed for the 3 
filovirus reaction patterns; 43% (4874 124) of the EBOV 
group but only 15.5% (851547) of the strain and family 
specific reactions had high titres (P<O.OI). The endpoint 
dilutions for EBOVZ and EBOVS reactions in the EBOV 
group-specific specimens were withifì-2- to d-fold dilu- 
tions. Monospecific MBGV sera tended to have high 
titres; 33% (16148) of the monospecific MBGV sera had 
titres 2128. 
Age and sex were important host-related factors in- 
fluencing filovirus antibody prevalences, particularly in 
the case of EBOV. The prevalence of high titre (2128) 
EBOV antibody increased with age. Older females and 
males had higher EBOV antibody prevalences than 
younger people of the same sex (Table 3). Young females 
Table 3. Sex and age distribution of individuals with high 
titres (21:128) in the indirect fluorescent antibody test against 
Ebola and Marburg viruses in the Central African Republic 
~~ 
Survey population 
Sex and No. positive (>1:128)" 
age (years) Total EBOV MBGV Total 
Female 
1-20 927 73 (7.9) 4 (0.4) 77 (8-3) 
21-40 672 76 (11.3) 5 (0.7) 8 1  (12.1) 
a41  333 50 (15.0) 8 (2.4) 58 (17.4) 
1-20 1186 43 (3.6) 7 (0.6) 50 (4.2) 
21-40 560 55 (9.8) 3 (0.5) 58 (10.4) 
241 400 38 (9.5) l(0-3) 39 (9.8) 
aNumbers in parentheses are percentages. EBOV=Ebola virus, 
MBGV=Marburg virus. 
Male 
had a higher prevalence than young males; the female 
and male prevalences become equivalent in the 21-40 
years age group (P=0.45). Although EBOV reactive anti- 
body prevalences were higher for females than for males 
in all ecological zones except the dry wooded grasslands, 
statistically signifïcant differences (P<O.O1) between the 
sexes were observed in the dry grasslands only (P<O.O1) 
(Table 4). Antibody prevalence rates were consistently 
higher in older than younger populations (Table 5 ) .  Stat- 
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Our results demonstrated that filovirus infections were 
common among residents of the Central African Repub- 
lic. Virus activity in diverse environments of equatorial 
Africa is influenced by sex andor age related factors. 
The infections appear to occur without apparent overt 
disease, suggesting that the African filoviruses may be 
less pathogenic in their natural settings than commonly 
thought. Most human filovirus disease has been de- 
scribed in epidemic settings, which may involve atypical 
odes of exposure (SIEGERT, 1970; JOHNSON, 1978; 
MITH, D. I. H,, 1978). 
Serological evidence of filovirus activity has been re- 
orded consistently for high risk groups in diverse eco- 
logical zones of central Africa since 1984 (MEUNIER et 
al., 1987). The majority of the filovirus seropositives 
-identified in our study expressed EBOV group speci- 
ficity, reacting with both the Zaire and Sudan EBOV 
strains. These observations are the first field serosurvev 
results supporting earlier findings indicating that EBO? 
exposure leads to broad filovirus group specific serologi- 
cal responses in humans (JOHNSON et al., 1978; WEBB et 
al., 1978; RICHMAN et al., 1983). 
The finding that only 27.4% of the seropositive spe- 
cimens we examined exhibited EBOV strain specific re- 
= 
activity was unexpected (Table l), though numerous 
EBOVZ strain specific responses have been reported by 
others (BLACKBURN et al., 1982; IVANOFF et al., 1982). 
The concept of mild immunizing EBOV infections has 
been difficult to accept in view of the high mortality and 
very low incidence of mild or subclinical infections ob- 
served during the Zaïre epidemic (JOHNSON, 1978). 
The virus specific reactions in our study may reflect 
distinct EBOV strain activity. If these antibodies are the 
results of a single exposure to one of the African EBOV 
strains, the resulting antibody response is of low titre 
(Table 2; <1:64 in 85% of subjects). Furthermore, the 
high EBOV group reactive antibody prevalence, which 
was greater than would be expected from the fraction of 
monospecific or EBOV strain specific reactions in the 
population tested, suggests that the EBOVs do not circu- 
late independently and that our study population shares 
common risk factors for exposure to the 2 viruses. 
An alternative interpretation of our data could be that 
EBOV infections induce the formation of group reactive 
antibody of varying specificities depending upon the 
virus strain, nature of exposure, and host reactivity. 
Virus specific reactions would, therefore, reflect a past 
infection in which the heterologous strain responses have 
decayed unequally, and EBOV group reactives would 
represent a recent infection. The latter interpretation, 
which we favour, is supported by the observation that 
non-fatal EBOV infections during the Zaïre outbreak fre- 
quently caused the production of short-lived, relatively 
Finding filovirus antibody seropositives demonstrating 
high-titre (JOHNSON et al., 1978) and cross-reactive anti- 




'k! both EBOV and MBGV Sero-reactivity was also unex- 
pected. This may be a consequence of multiple filovirus 
exposures among a small group of Central African Re- 
public inhabitants. The distribution of MBGV antibody 
titres may support the possibility of recurring filovirus 
infections. MBGV reactions accompanied EBOV anti- 
bodies in a hi her proportion than expected from the 
number of EB8V or MBGV monospecific reactors in the 
study group. In contrast to the situation with EBOV 
group reactions, none of the filovirus famlly reactions 
had high titres of MBGV reactive antibody, while 33% 
(16/48) of the MBGV specific responses were greater 
than, or equal to, 128. This may reflect the lack of a de- 
tectable serological relationship between MBGV and 
EBOV (WEBB et al., 1978; RICHMAN et al., 1983). 
The frequency of low filovirus antibody titres often 
observed in African HFV Sero-surveys deserves com- 
ment; 0.3% (3/996) and 0.5% (1/200) of human samples 
collected in non-endemic areas, France and Panama (J. 
P. Gonzalez et al., paper in preparation; VAN DER 
GROEN et al., 1978), respectively, had low antibody titres 
to Ebola virus. These low prevalences and low titre 
(<1:64) reactions in populations without an African ex- 
posure history suggest that some of the low titre filovirus 
Sero-reactives observed in our survey were false posi- 
tives. However, the distribution of EBOV IFAT titres 
(Table 2) is similar to that observed during Sero-surveys 
in regions of Central and West Africa where HFV activ- 
ity has been confirmed by virus isolation from clinical 
specimens (MCCORMICK et al., 1987). Our conclusion, 
that filovirus activity has occurred in the Central African 
Republic, is unchanged by basing it on only high titre 
(2128) IFAT reactions. At least 11.2% of the female and 
6.8% of the male populations have been exposed (Table 
3). Age specific prevalence rates for the 1-20 years old 
age group suggest that young females are exposed more 
frequently than are males of the same age group 
(P<O.Ol). The statistically significant differences be- 
tween female and male EBOV reactive antibody pre- 
valences observed in our study are not unique, similar 
observations having been made during sero-epidemio- 
logical studies in northern Zaïre (HEYMANN et al., 1980). 
Filovirus activity in the Central African Republic was 
not limited to a specific habitat. Serological evidence of 
human infection was found in all ecological zones, 
though MBGV infections were rare in the dense forest. 
This contrasts with the previous report of EBOV anti- 
bodies being confined to forest populations ( JOHNSON, 
1978; SMITH, D. I. H., 1978; VAN DER GROEN et  al., 
1978). The observation that filovirus family specific sero- 
positives occurred among grassland populations where 
EBOV and MBGV Co-exist may indicate the presence of 
a unique human population expressing cultural or beha- 
vioural risk factors for both EBOV and MBGV infections 
or filovirus re-infections (Table 1). The variation in anti- 
body prevalence between ecological zones may indicate 
the importance of host-related factors in regulating 
human filovirus exposures rather than differential circu- 
lation of filoviruses. Unfortunately, the putative risk fac- 
tors were not identified due to the low frequency (2.4%) 
of filovirus family specific seropositives among diverse 
grassland populations. 
Sex and/or age were clearly identified as important risk 
factors for filovirus infections in both dry grassland and 
moist forest communities (Tables 4 and 5). Communities 
in these ecological zones differ from those in the more 
centrally located wooded grasslands. Rural communities 
of the less populated far northern and southern zones are 
geographically isolated with little influence from outside 
factors, and people in these communities interact closely 
with their immediate natural environment without caus- 
ing dramatic changes in the ecosystem. The high filo- 
virus prevalence in females (Table 4) suggests that filo- 
virus exposure may be a notable health risk for women 
living in the Central African Republic. Subsistence acti- 
vities are a primary responsibility of rural women; men 
spend less time on them (HEWETT, 1991). Young and 
old women share a close association with the family com- 
pound and fields. Males (>6 years old) associate less with 
the family compound or crops (MURDOCK & PROVOST, 
1973). The high filovirus prevalence among young 
women (Table 3) suggests that filovirus exposure may 
occur within the family compound. The prevalence of 
filovirus antibody in guinea-pigs maintained as a sup- 
plemental food source in kitchen huts in Zaïre (STANS- 
FIELD et al., 1982) may support this view. 
The significance of similar antibody prevalences in the 
remote northern and southern regions of the Central Af- 
rican Republic must be interpreted carefully. The grass- 
land and forest zones share many factors, but there are 
significant differences in agricultural practices and ethnic 
backgrounds, which may also affect risk (BAUREE Sr 
BERGMANN, 1983). The grassland survey population 
consisted of cultivators and/or pastoralists. The forest 
communities were comprised of agriculturalists and 
hunter-gatherers; subsistence farmers infrequently hunt 
and hunter-gatherers seldom cultivate vegetable foods. 
Although our Sero-epidemiological surveys clearly do- 
cumented non-fatal filovirus infections, the results do not 
resolve the paradox of significant antibody prevalence for 
the highly virulent filoviruses without demonstrable dis- 
ease in Central Africa. Continued surveillance and in- 
tense epidemiological investigations are needed to evalu- 
ate the true pathogenicity of the African filoviruses and 
the likelihood that unidentified, serologically cross-reac- 
ting and non-pathogenic members of the filovirus family 
are present in the region (MEUNIER et al., 1987). The re- 
cent isolation of a presumptive Asian filovirus from Phil- 
ippine monkeys (Macaca fascicularis) emphasizes the 
possibility that additional filoviruses may be active also 
in sub-Saharan Africa (JAHRLING et al., 1990); these 
viruses could resemble the newly isolated strain in being 
serologically cross-reactive with, bqt distinguishable 
from, the Zaïre and Sudan EBOV strains and less pa- 
thogenic for man. Based upon our results, the search for 
Ebola annd Marburg viral infections in central Africa 
should be conducted in non-urban moist forest and dry 
grassland communities where serological evidence sug- 
gests frequent but non-fatal infections. The probability 
of successfully resolving the paradox may be increased by 
focusing upon defining the relationship between filovirus 
Sero-reactivity and sex-specific subsistence strategies 
practised in equatorial Africa. 
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